Haemophilia Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Haemophilia stocks.

Haemophilia Stocks Recent News

Date Stock Title
Nov 20 NVO More companies covering weight loss drugs for their employees
Nov 20 NVO Weight loss drug makers want more insurance plans to cover Wegovy and Zepbound
Nov 20 NVO Is Novo Nordisk Stock a Buy Right Now?
Nov 20 NVO RFK Jr. Sparks New Worries About Obesity Drugs. Here’s What Investors Should Focus on Instead.
Nov 19 NVO Novo Nordisk semaglutide phase 3 trial for MASH meets primary endpoints
Nov 19 NVO Sector Update: Health Care Stocks Decline
Nov 19 NVO Novo Nordisk Unusual Options Activity For November 19
Nov 19 NVO Sector Update: Health Care Stocks Mixed Tuesday Afternoon
Nov 19 NVO Novo Erases 2024 Gain, Wiping Out $210 Billion in Value
Nov 19 NVO Market Chatter: Eli Lilly, Novo Nordisk Press Employers to Cover the Cost of Weight-Loss Drugs
Nov 19 NVO Employers Get Pressure to Pay for Drugs Like Wegovy
Nov 18 NVO RFK Jr.'s HHS nomination sparks concern over pharma stocks
Nov 18 NVO Novo Nordisk reportedly launches Wegovy in China
Nov 18 NVO How Robert F. Kennedy Jr. could impact the healthcare sector as secretary of health
Nov 18 NVO Market Chatter: Eli Lilly, Novo Nordisk Obesity Drugs Covered Mostly by Medicaid, Analysts Say
Nov 18 NVO Exclusive: Medicaid fuels US coverage of Novo, Lilly weight-loss drugs
Nov 16 NVO The weight-loss frenzy is making some pharma stocks much more volatile. Will the drama continue?
Nov 15 NVO Powell Speaks The Truth - Market Does Not Like It, Consternation About Kennedy, Gaetz, And Hegseth
Nov 15 NVO Heard on the Street: RFK Jr. Is Spooking Obesity Investors Too
Nov 15 NVO Novo Nordisk A/S (NVO) Trembled At The End Of The Quarter
Haemophilia

Haemophilia is a mostly inherited genetic disorder that impairs the body's ability to make blood clots, a process needed to stop bleeding. This results in people bleeding for a longer time after an injury, easy bruising, and an increased risk of bleeding inside joints or the brain. Those with a mild case of the disease may have symptoms only after an accident or during surgery. Bleeding into a joint can result in permanent damage while bleeding in the brain can result in long term headaches, seizures, or a decreased level of consciousness.There are two main types of haemophilia: haemophilia A, which occurs due to low amounts of clotting factor VIII, and haemophilia B, which occurs due to low levels of clotting factor IX. They are typically inherited from one's parents through an X chromosome carrying a nonfunctional gene. Rarely a new mutation may occur during early development or haemophilia may develop later in life due to antibodies forming against a clotting factor. Other types include haemophilia C, which occurs due to low levels of factor XI, and parahaemophilia, which occurs due to low levels of factor V. Acquired haemophilia is associated with cancers, autoimmune disorders, and pregnancy. Diagnosis is by testing the blood for its ability to clot and its levels of clotting factors.Prevention may occur by removing an egg, fertilizing it, and testing the embryo before transferring it to the uterus. Treatment is by replacing the missing blood clotting factors. This may be done on a regular basis or during bleeding episodes. Replacement may take place at home or in hospital. The clotting factors are made either from human blood or by recombinant methods. Up to 20% of people develop antibodies to the clotting factors which makes treatment more difficult. The medication desmopressin may be used in those with mild haemophilia A. Studies of gene therapy are in early human trials.Haemophilia A affects about 1 in 5,000–10,000, while haemophilia B affects about 1 in 40,000, males at birth. As haemophilia A and B are both X-linked recessive disorders, females are rarely severely affected. Some females with a nonfunctional gene on one of the X chromosomes may be mildly symptomatic. Haemophilia C occurs equally in both sexes and is mostly found in Ashkenazi Jews. In the 1800s haemophilia B was common within the royal families of Europe. The difference between haemophilia A and B was determined in 1952. The word is from the Greek haima αἷμα meaning blood and philia φιλία meaning love.

Browse All Tags